Application of ultra-low dose and low specific gravity combined spinal-epidural anesthesia in patients with hip fracture complicated with uremia

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000038266

Enrollment

Unknown

Registered

2020-09-15

Start date

2020-09-29

Completion date

Unknown

Last updated

2020-12-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip Fracture

Interventions

Experimental Group:Ultralow dose low specific gravity spinal anesthesia

Control Group:Conventional dose low specific gravity lumbar anesthesia

Eligibility

Sex/Gender

All

Age

45 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Patients with unilateral hip fracture are scheduled to be operated within 24-72 hours. 2. Patients with chronic renal failure in uremic stage should be treated with regular dialysis. 3. Patients aged 45-85 years, weighing 53-82 kg, ASA grade III-IV, BNP 300-1500 pg / ml. 4. The patients who can communicate easily and have been literated enough to read and sign informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients refused to be punctured. 2. Patients with multiple trauma, the trauma beyond one limb, fracture of prosthesis, or intraoperative application of bone cement. 3. Patients have had a stroke in the last three months. 4. Patients with active heart disease (unstable angina, myocardial infarction, recent myocardial infarction, symptomatic arrhythmia, severe mitral or aortic stenosis). 5. Patients have recently participated in other clinical studies.

Design outcomes

Primary

Measure	Time frame
Anesthesia plane;	—

Countries

China

Contacts

Public ContactLiu Peng

The Third Hospital of Hebei Medical University

liupeng2010aa@126.com+86 18931197603

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026